INTRODUCTION: Intravenous recombinant tissue plasminogen activator (IV-rtPA) is the standard therapy for acute ischaemic stroke. Because of its narrow therapeutic time window, eligibility and utilisation rates of this treatment remained low. Our IV-rtPA programme was enhanced to a 24/7 protocol since September 20…published_or_final_versio